Article metrics

Download PDFPDF

Commentary
Response to commentary: Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study – determination of immunogenicity

 

Online download statistics by month:

Online download statistics by month:

No statistics are available.